The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABIVAX SA | SPONSORED ADS | 00370M103 | 24,537,600 | 2,130,000 | SH | DFND | 1 | 2,130,000 | 0 | 0 | ||
ALUMIS INC | COM | 022307102 | 22,934,189 | 2,147,396 | SH | DFND | 1 | 2,147,396 | 0 | 0 | ||
ANAPTYSBIO INC | COM | 032724106 | 11,472,578 | 342,465 | SH | DFND | 1 | 342,465 | 0 | 0 | ||
ARCELLX INC | COMMON STOCK | 03940C100 | 104,387,500 | 1,250,000 | SH | DFND | 1 | 1,250,000 | 0 | 0 | ||
ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | 21,622,500 | 2,325,000 | SH | DFND | 1 | 2,325,000 | 0 | 0 | ||
ARRIVENT BIOPHARMA INC | COM | 04272N102 | 13,758,357 | 585,462 | SH | DFND | 1 | 585,462 | 0 | 0 | ||
ARTIVA BIOTHERAPEUTICS INC | COM | 04317A107 | 1,601,130 | 103,633 | SH | DFND | 1 | 103,633 | 0 | 0 | ||
AVIDITY BIOSCIENCES INC | COM | 05370A108 | 48,226,500 | 1,050,000 | SH | DFND | 1 | 1,050,000 | 0 | 0 | ||
AXSOME THERAPEUTICS INC | COM | 05464T104 | 35,948,000 | 400,000 | SH | DFND | 1 | 400,000 | 0 | 0 | ||
BIOAGE LABS INC | COM | 09077V100 | 33,894,203 | 1,629,529 | SH | DFND | 1 | 1,629,529 | 0 | 0 | ||
BIOHAVEN LTD | COM | G1110E107 | 20,086,091 | 401,963 | SH | DFND | 1 | 401,963 | 0 | 0 | ||
BIOMEA FUSION INC | COM | 09077A106 | 36,065,807 | 3,570,872 | SH | DFND | 1 | 3,570,872 | 0 | 0 | ||
BRIDGEBIO PHARMA INC | COM | 10806X102 | 47,313,616 | 1,858,351 | SH | DFND | 1 | 1,858,351 | 0 | 0 | ||
CARGO THERAPEUTICS INC | COM | 14179K101 | 21,818,287 | 1,182,563 | SH | DFND | 1 | 1,182,563 | 0 | 0 | ||
CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | 40,959,984 | 2,561,600 | SH | DFND | 1 | 2,561,600 | 0 | 0 | ||
CG ONCOLOGY INC | COM | 156944100 | 36,786,750 | 975,000 | SH | DFND | 1 | 975,000 | 0 | 0 | ||
CORBUS PHARMACEUTICALS HLDGS | COM NEW | 21833P301 | 48,996,250 | 2,375,000 | SH | DFND | 1 | 2,375,000 | 0 | 0 | ||
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 56,210,000 | 1,100,000 | SH | DFND | 1 | 1,100,000 | 0 | 0 | ||
EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 90,920,392 | 3,406,534 | SH | DFND | 1 | 3,406,534 | 0 | 0 | ||
ENGENE HOLDINGS INC | COM | 29286M105 | 6,600,000 | 1,000,000 | SH | DFND | 1 | 1,000,000 | 0 | 0 | ||
EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 66,516,750 | 8,325,000 | SH | DFND | 1 | 8,325,000 | 0 | 0 | ||
GH RESEARCH PLC | ORDINARY SHARES | G3855L106 | 3,967,458 | 593,043 | SH | DFND | 1 | 593,043 | 0 | 0 | ||
HELIX ACQUISITION CORP II | CL A ORD SHS | G4444H101 | 30,398,759 | 2,909,000 | SH | DFND | 1 | 2,909,000 | 0 | 0 | ||
INSMED INC | COM PAR $.01 | 457669307 | 36,500,000 | 500,000 | SH | DFND | 1 | 500,000 | 0 | 0 | ||
JANUX THERAPEUTICS INC | COM | 47103J105 | 47,701,500 | 1,050,000 | SH | DFND | 1 | 1,050,000 | 0 | 0 | ||
KORRO BIO INC | COM | 500946108 | 8,883,905 | 265,826 | SH | DFND | 1 | 265,826 | 0 | 0 | ||
LONGBOARD PHARMACEUTICALS IN | COM | 54300N103 | 93,006,098 | 2,790,462 | SH | DFND | 1 | 2,790,462 | 0 | 0 | ||
MBX BIOSCIENCES INC | COM | 55287L101 | 18,186,000 | 700,000 | SH | DFND | 1 | 700,000 | 0 | 0 | ||
MERUS N V | COM | N5749R100 | 36,970,400 | 740,000 | SH | DFND | 1 | 740,000 | 0 | 0 | ||
MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | 428,275,093 | 8,494,151 | SH | DFND | 1 | 8,494,151 | 0 | 0 | ||
NEUROGENE INC | COM | 64135M105 | 4,504,154 | 107,344 | SH | DFND | 1 | 107,344 | 0 | 0 | ||
NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | N62509109 | 41,002,000 | 2,470,000 | SH | DFND | 1 | 2,470,000 | 0 | 0 | ||
PHARVARIS N V | COM | N69605108 | 27,158,839 | 1,466,460 | SH | DFND | 1 | 1,466,460 | 0 | 0 | ||
PRAXIS PRECISION MEDICINES I | COM NEW | 74006W207 | 50,059,800 | 870,000 | SH | DFND | 1 | 870,000 | 0 | 0 | ||
RAPPORT THERAPEUTICS INC | COM | 75383L102 | 60,230,062 | 2,940,921 | SH | DFND | 1 | 2,940,921 | 0 | 0 | ||
RAPT THERAPEUTICS INC | COM | 75382E109 | 998,468 | 496,750 | SH | DFND | 1 | 496,750 | 0 | 0 | ||
RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | 20,956,000 | 400,000 | SH | DFND | 1 | 400,000 | 0 | 0 | ||
SILENCE THERAPEUTICS PLC | ADS | 82686Q101 | 7,272,000 | 400,000 | SH | DFND | 1 | 400,000 | 0 | 0 | ||
STOKE THERAPEUTICS INC | COM | 86150R107 | 5,249,833 | 427,163 | SH | DFND | 1 | 427,163 | 0 | 0 | ||
TARSUS PHARMACEUTICALS INC | COM | 87650L103 | 16,445,000 | 500,000 | SH | DFND | 1 | 500,000 | 0 | 0 | ||
UROGEN PHARMA LTD | COM | M96088105 | 19,685,000 | 1,550,000 | SH | DFND | 1 | 1,550,000 | 0 | 0 | ||
VAXCYTE INC | COM | 92243G108 | 114,270,000 | 1,000,000 | SH | DFND | 1 | 1,000,000 | 0 | 0 | ||
VERVE THERAPEUTICS INC | COM | 92539P101 | 1,694,000 | 350,000 | SH | DFND | 1 | 350,000 | 0 | 0 | ||
VYNE THERAPEUTICS INC | COM | 92941V308 | 2,621,352 | 1,394,336 | SH | DFND | 1 | 1,394,336 | 0 | 0 | ||
Y-MABS THERAPEUTICS INC | COM | 984241109 | 19,067,500 | 1,450,000 | SH | DFND | 1 | 1,450,000 | 0 | 0 |